TY  - GEN
AU  - Eiring,A M
AU  - Khorashad,J S
AU  - Anderson,D J
AU  - Yu,F
AU  - Redwine,H M
AU  - Mason,C C
AU  - Reynolds,K R
AU  - Clair,P M
AU  - Gantz,K C
AU  - Zhang,T Y
AU  - Pomicter,A D
AU  - Kraft,I L
AU  - Bowler,A D
AU  - Johnson,K
AU  - Partlin,M Mac
AU  - O'Hare,T
AU  - Deininger,M W
TI  - β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
SN  - 1476-5551
PY  - 2016///0413
KW  - Cadherins
KW  - physiology
KW  - Cell Line, Tumor
KW  - Drug Resistance, Neoplasm
KW  - Fusion Proteins, bcr-abl
KW  - Humans
KW  - Imatinib Mesylate
KW  - therapeutic use
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Protein Kinase Inhibitors
KW  - Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
KW  - Proto-Oncogene Proteins
KW  - Wnt Proteins
KW  - Wnt-5a Protein
KW  - beta Catenin
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2015.196
ER  -